Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Mayne Pharma Group Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Mayne Pharma Acquires Efudex from Spear Pharma 13
Mayne Pharma Acquires Rights to Foam Assets from GlaxoSmithKline for USD50 Million 14
Mayne Pharma Acquires US Generic Products from Teva Pharma and Allergan for USD652 Million 15
Mayne Pharma to Acquire Doryx from Actavis for USD50 Million 17
Mayne Pharma Acquires Brands And Related Assets For Forest Labs For US$12 Million 18
Mayne Pharma Acquires Kapanol from GlaxoSmithKline for USD15 Million 19
Venture Financing 20
HedgePath Pharma Raises USD0.6 Million in Financing 20
Partnerships 21
Mayne Pharma Enters into Distribution Agreement with IDT Australia 21
Mayne Pharma Enters Into Distribution Agreement With ISDIN For Subacap 22
Mayne Pharma Enters Into Distribution Agreement With Glenmark Pharma For Subacap 24
Licensing Agreements 26
HedgePath Pharma Enters into Option Agreement with University of Connecticut 26
Mayne Pharma Enters into Licensing Agreement with Nestle Skin Health 27
HedgePath Pharma Enters into Sublicensing Agreement with Mayne Pharma 28
HedgePath Pharma Amends Licensing Agreement With Mayne Pharma 29
Mayne Pharma Group Enters Into Licensing Agreement With Intas Pharma For Injectable Products 31
Equity Offering 32
HedgePath Pharma Raises USD1.6 Million in Second Tranche of Private Placement of Preferred Shares 32
HedgePath Pharma Raises USD2.4 Million in First Tranche of Private Placement of Preferred Shares 33
Mayne Pharma Raises USD257 Million in Rights Offering of Shares 34
Mayne Pharma to Raise USD212 Million in Private Placement of Shares 36
HedgePath Pharma Raises USD5.5 Million in Private Placement of Units 38
HedgePath Pharma Raises USD2.5 Million in Private Placement of Shares and Warrants 39
HedgePath Pharma Completes Private Placement of Shares for USD1.5 Million 40
Mayne Pharma Completes Private Placement Of Shares For US$16 Million 41
Mayne Pharma Group Completes Private Placement Of Shares For US$5 Million 42
Mayne Pharma Group Completes Private Placement Of Shares For US$0.14 Million 43
Mayne Pharma Group Completes Private Placement Of Shares For US$19 Million 44
Mayne Pharma Completes Final Tranche Of Private Placement Of Shares For US$4 Million 46
Acquisition 47
Mayne Pharma Acquires Libertas Pharma, Generic Pharma Company 47
Mayne Pharma Completes Acquisition Of Metrics For Up To US$120 Million 48
Mayne Pharma Group Ltd – Key Competitors 50
Mayne Pharma Group Ltd – Key Employees 51
Mayne Pharma Group Ltd – Locations And Subsidiaries 52
Head Office 52
Other Locations & Subsidiaries 52
Recent Developments 54
Strategy And Business Planning 54
Apr 18, 2018: Mayne Pharma Opens New Solid Oral-dose Manufacturing Facility In US 54
Financial Announcements 55
Feb 23, 2018: Mayne Pharma Reports 2018 Half Year Performance 55
Aug 25, 2017: Mayne Pharma Reports FY17 Results 58
Feb 24, 2017: Mayne Pharma: 2017 Half Year Release 61
Corporate Communications 64
Jun 28, 2018: Mayne Pharma Names Patrick Blake As New Director 64
May 30, 2018: Mayne Pharma Announces New Board Director 65
Mar 09, 2017: Mayne Pharma appoints new Group CFO and Company Secretary 66
Jan 16, 2017: Mayne Pharma Announces Leadership Changes 67
Other Significant Developments 69
Aug 08, 2017: Mayne Pharma Market Update 69
Appendix 71
Methodology 71
About GlobalData 71
Contact Us 71
Disclaimer 71
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Mayne Pharma Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Mayne Pharma Group Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mayne Pharma Acquires Efudex from Spear Pharma 13
Mayne Pharma Acquires Rights to Foam Assets from GlaxoSmithKline for USD50 Million 14
Mayne Pharma Acquires US Generic Products from Teva Pharma and Allergan for USD652 Million 15
Mayne Pharma to Acquire Doryx from Actavis for USD50 Million 17
Mayne Pharma Acquires Brands And Related Assets For Forest Labs For US$12 Million 18
Mayne Pharma Acquires Kapanol from GlaxoSmithKline for USD15 Million 19
HedgePath Pharma Raises USD0.6 Million in Financing 20
Mayne Pharma Enters into Distribution Agreement with IDT Australia 21
Mayne Pharma Enters Into Distribution Agreement With ISDIN For Subacap 22
Mayne Pharma Enters Into Distribution Agreement With Glenmark Pharma For Subacap 24
HedgePath Pharma Enters into Option Agreement with University of Connecticut 26
Mayne Pharma Enters into Licensing Agreement with Nestle Skin Health 27
HedgePath Pharma Enters into Sublicensing Agreement with Mayne Pharma 28
HedgePath Pharma Amends Licensing Agreement With Mayne Pharma 29
Mayne Pharma Group Enters Into Licensing Agreement With Intas Pharma For Injectable Products 31
HedgePath Pharma Raises USD1.6 Million in Second Tranche of Private Placement of Preferred Shares 32
HedgePath Pharma Raises USD2.4 Million in First Tranche of Private Placement of Preferred Shares 33
Mayne Pharma Raises USD257 Million in Rights Offering of Shares 34
Mayne Pharma to Raise USD212 Million in Private Placement of Shares 36
HedgePath Pharma Raises USD5.5 Million in Private Placement of Units 38
HedgePath Pharma Raises USD2.5 Million in Private Placement of Shares and Warrants 39
HedgePath Pharma Completes Private Placement of Shares for USD1.5 Million 40
Mayne Pharma Completes Private Placement Of Shares For US$16 Million 41
Mayne Pharma Group Completes Private Placement Of Shares For US$5 Million 42
Mayne Pharma Group Completes Private Placement Of Shares For US$0.14 Million 43
Mayne Pharma Group Completes Private Placement Of Shares For US$19 Million 44
Mayne Pharma Completes Final Tranche Of Private Placement Of Shares For US$4 Million 46
Mayne Pharma Acquires Libertas Pharma, Generic Pharma Company 47
Mayne Pharma Completes Acquisition Of Metrics For Up To US$120 Million 48
Mayne Pharma Group Ltd, Key Competitors 50
Mayne Pharma Group Ltd, Key Employees 51
Mayne Pharma Group Ltd, Other Locations 52
Mayne Pharma Group Ltd, Subsidiaries 52
List of Figures
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Mayne Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Mayne Pharma Group Ltd, Medical Devices Deals, 2012 to YTD 2018 10